Microbial Bioactives
Microbial Bioactives | Online ISSN 2209-2161
295
Citations
200.6k
Views
166
Articles
Volume 5 Number 1 2022
RESEARCH ARTICLE (Open Access)
The Status of Extended-spectrum β-lactamase and AmpC β-lactamase production in uropathogenic isolates of Escherichia coli and Klebsiella pneumonia in Bangladesh
Md. Habibur Rahman 1,2, Shamima Begum 1*, Mushtaque Ahmed 1, Ariful Islam 1
Microbial Bioactives 5 (1) 181-189 https://doi.org/10.25163/microbbioacts.512133
Submitted: 01 November 2021 Revised: 30 May 2022 Published: 20 June 2022
Abstract
Background: The rapid dissemination of antibiotic resistance as extended-spectrum beta-lactamases (ESBLs) and AmpC β-lactamases in bacteria became a major public health concern worldwide. Hence, this study was carried out to evaluate the status of uropathogenic isolates of Bangladesh especially Escherichia coli and Klebsiella pneumoniae in terms of ESBL and AmpC β-lactamases enzymes production. Methods: A laboratory-based cross-sectional survey was conducted with 553 urine samples at the Department of Microbiology, Popular Diagnostic Centre Ltd. Dhaka, Bangladesh for a period of 2.5 years from July 2017 to December 2019. Pathogens were obtained upon culture, and screened for ESBL production following the cephalosporin disk diffusion method and cephalosporin-clavulanate combination disc test (confirmatory) method. For AmpC β-lactamases enzymes, cefoxitin disc diffusion, and AmpC disc test (confirmatory) methods were performed. The positive isolates were further genotyped for the presence of blaTEM, blaSHV, blaOXA, and blaCTX-M β-lactamases genes in case of ESBL and blaFOX, blaCMY, and blaDHA genes for AmpC β-lactamases by polymerase chain reaction. Results: Of all urine samples, uropathogens were detected among 28.57% (158, n=553) samples. Among them, 46.20% (73) were E. coli and 20.25% (32) were K. pneumoniae. The prevalence of ESBL and AmpC β-lactamases production in E. coli was 34.24% (25) and 17.80% (13) respectively whereas it was 43.75% (14) and 21.87% (7) in Klebsiella pneumoniae isolates respectively. These resistance properties were further confirmed by phenotypic disc test. In case of ESBLs, most typical isolates possessed two or more resistance genes. Overall, the most prevalent gene was blaCTX-M (84.61%) followed by blaTEM (64.10%), blaOXA (46.15%) and blaSHV (25.64%). In case of AmpC β-lactamases FOX gene was most prevalent (45%) followed by CMY (20%) and DHA 3 (15%). Conclusion: The high prevalence of ESBL and AmpC β-lactamases production in our study emphasizes the judicious use of antibiotics in controlling urinary tract infections in Bangladesh.
Keywords: Urinary tract infection; Uropathogens; Extended-spectrum β-lactamase; AmpC β-lactamase; Escherichia coli; Klebsiella pneumoniae; Antimicrobial resistance; Bangladesh
References
Altoparlak, U., Erol, S., Akcay, M. N., Celebi, F., & Kadanali, A. (2004). Time-related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns, 30(7), 660–664. https://doi.org/10.1016/j.burns.2004.03.005
Arora, S., & Bal, M. (2005). AmpC β-lactamase-producing bacterial isolates from a Kolkata hospital. Indian Journal of Medical Research, 122, 224–233.
Auer, S., Wojna, A., & Hell, M. (2010). Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Antimicrobial Agents and Chemotherapy, 54(9), 4006–4008. https://doi.org/10.1128/AAC.01760-09
Bandekar, N., Kumar, V. C. S., Basavarajappa, K. G., et al. (2011). Beta-lactamase-mediated resistance amongst Gram-negative bacilli in burn infection. International Journal of Biological and Medical Research, 2(3), 766–770.
Black, J. A., Moland, E. S., & Thomson, K. S. (2005). AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-lactamases. Journal of Clinical Microbiology, 43(7), 3110–3113. https://doi.org/10.1128/JCM.43.7.3110-3113.2005
Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clinical Microbiology Reviews, 14(4), 933–951. https://doi.org/10.1128/CMR.14.4.933-951.2001
Bristy, F. S., Uddin, M. R., Mahmud, S. A., Uddin, M. J., Talukder, A. A., Khondoker, M. U., Jamiruddin, M. R., Azmuda, N., & Adnan, N. (2018). Reassessment of clinical pathogens diagnosed by suburban facilities of Dhaka: Necessity of comprehensive techniques to manage antibiotic resistance. Microbial Bioactives, 1(2), 51–58. https://doi.org/10.25163/microbbioacts.12013C0207101018
Centers for Disease Control and Prevention (CDC). (1999). Laboratory detection of extended-spectrum beta-lactamases (ESBLs). http://www.cdc.gov/ncidod/hip
Chandel, D. S., Johnson, J. A., Chaudhry, R., et al. (2011). ESBL-producing Gram-negative bacteria causing neonatal sepsis in India in rural and urban settings. Journal of Medical Microbiology, 60(4), 500–507. https://doi.org/10.1099/jmm.0.027375-0
Edelstein, M., Pimkin, M., Palagin, I., Edelstein, I., & Stratchounski, L. (2003). Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrobial Agents and Chemotherapy, 47(12), 3724–3732. https://doi.org/10.1128/AAC.47.12.3724-3732.2003
Ejaz, H., Zafar, A., Anwar, N., Cheema, T. A., & Shehzad, H. (2006). Prevalence of bacteria in urinary tract infections among children. Biomedica, 22.
Govindaswamy, A., Bajpai, V., Batra, P., Malhotra, R., & Mathur, P. (2018). Phenotypic and molecular characterization of extended-spectrum β-lactamase and AmpC β-lactamases in Escherichia coli from a tertiary care centre in India. Journal of Patient Safety and Infection Control, 6. https://doi.org/10.4103/jpsic.jpsic_11_18
Goyal, A., Prasad, K. N., Prasad, A., Gupta, S., Ghoshal, U., Ayyagari, A., et al. (2009). Extended-spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae and associated risk factors. Indian Journal of Medical Research, 129, 695–700.
Hasan, B., Islam, K., Ahsan, M., Hossain, Z., Rashid, M., et al. (2014). Fecal carriage of multidrug-resistant and extended-spectrum β-lactamase-producing Escherichia coli in household pigeons, Bangladesh. Veterinary Microbiology, 168(1), 221–224. https://doi.org/10.1016/j.vetmic.2013.09.033
Hemalatha, V., Padma, M., Sekar, U., Vinodh, T. M., & Arunkumar, A. S. (2007). Detection of AmpC β-lactamase production in Escherichia coli and Klebsiella by an inhibitor-based method. Indian Journal of Medical Research, 126(3), 220–223.
Humayun, T., & Iqbal, A. (2012). Culture and sensitivity pattern of urinary tract infections in females of reproductive age group. Annals of Pakistan Institute of Medical Sciences, 8(1), 19–22.
Ahmed, I., & Salam, A. (2002). Extended-spectrum β-lactamases and bacterial resistance. Pakistan Journal of Medical Sciences, 18(2), 151–155.
Iraj, A., & Nilufar, Y. N. (2010). Antibiogram of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from hospital samples, Bangladesh. Bangladesh Journal of Medical Microbiology, 4(1), 32–33. https://doi.org/10.3329/bjmm.v4i1.8467
Khan, M. K. R., Thukral, S. S., & Gaind, R. (2008). Evaluation of a modified double-disc synergy test for detection of extended-spectrum β-lactamases in AmpC β-lactamase-producing Proteus mirabilis. Indian Journal of Medical Microbiology, 26(1), 58–61. https://doi.org/10.1016/S0255-0857(21)01994-0
Khan, M. N., Srivastava, P., Chophi, V., & Nirwan, P. S. (2015). Prevalence of ESBL and AmpC β-lactamase in Gram-negative bacilli in various clinical samples at a tertiary care hospital. International Research Journal of Medical Sciences, 3(8), 1–6.
Clinical and Laboratory Standards Institute (CLSI). (2017). Performance standards for antimicrobial susceptibility testing (27th ed., CLSI supplement M100-S27). https://www.clsi.org/standards/products/microbiology/documents/m100/
Manoharan, A., Sugumar, M., Kumar, A., Jose, H., Mathai, D., Khilnani, G. C., et al. (2012). Phenotypic and molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp., and Enterobacter spp. from five Indian medical centers. Indian Journal of Medical Research, 135, 359–364.
Mayo, S. J., Aboud, S., Kasubi, M., Lyamuya, E. F., & Maselle, S. Y. (2010). Antimicrobial resistance among producers and non-producers of extended-spectrum β-lactamases in urinary isolates at a tertiary hospital in Tanzania. BMC Research Notes, 3, 348. https://doi.org/10.1186/1756-0500-3-348
Medeiros, A. A. (1993). Nosocomial outbreaks of multiresistant bacteria: Extended-spectrum beta-lactamases have arrived in North America. Annals of Internal Medicine, 119(5), 428–429. https://doi.org/10.7326/0003-4819-119-5-199309010-00015
Moland, E. S., Black, J. A., Ourada, J., Reisbig, M. D., Hanson, N. D., & Thomson, K. S. (2002). Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrobial Agents and Chemotherapy, 46(12), 3837–3842. https://doi.org/10.1128/AAC.46.12.3837-3842.2002
Mugnaioli, C., Luzzaro, F., De Luca, F., Brigante, G., Perilli, M., et al. (2006). CTX-M-type extended-spectrum β-lactamases in Italy: Molecular epidemiology of an emerging countrywide problem. Antimicrobial Agents and Chemotherapy, 50(8), 2700–2706. https://doi.org/10.1128/AAC.00068-06
National Committee for Clinical Laboratory Standards (NCCLS). (1999). Performance standards for antimicrobial susceptibility testing (Approved Standard M100-S9). NCCLS.
Nemeth, J., Ledergerber, B., Preiswerk, B., Nobile, A., Karrer, S., Ruef, C., et al. (2012). Multidrug-resistant bacteria in travelers hospitalized abroad: Prevalence, characteristics, and influence on clinical outcome. Journal of Hospital Infection, 82(4), 254–259. https://doi.org/10.1016/j.jhin.2012.08.017
Parveen, R. M., Khan, M. A., Menezes, G. A., Harish, B. N., Parija, S. C., Hays, J. P., et al. (2011). Extended-spectrum β-lactamase-producing Klebsiella pneumoniae from blood cultures in Puducherry, India. Indian Journal of Medical Research, 134, 392–395.
Patel, M. H., Trivedi, G. R., Patel, S. M., & Vegad, M. M. (2010). Antibiotic susceptibility pattern in urinary isolates of Gram-negative bacilli with special reference to AmpC β-lactamase in a tertiary care hospital. Urology Annals, 2(1), 7–11. https://doi.org/10.4103/0974-7796.62915
Polsfuss, S., Bloemberg, G. V., Giger, J., et al. (2011). Practical approach for reliable detection of AmpC β-lactamase-producing Enterobacteriaceae. Journal of Clinical Microbiology, 49(8), 2798–2803. https://doi.org/10.1128/JCM.00404-11
Prelog, M., Fille, M., Prodinger, W., Grif, K., Brunner, A., et al. (2008). CTX-M-1-related extended-spectrum β-lactamase-producing Escherichia coli: So far, a sporadic event in Western Austria. Infection, 36(4), 362–367. https://doi.org/10.1007/s15010-008-7309-7
Qureshi, A. M. (2005). Organisms causing urinary tract infection in pediatric patients at Ayub Teaching Hospital Abbottabad. Journal of Ayub Medical College Abbottabad, 17(1), 72–74.
Rahman, M. M., Haq, J. A., Hossain, M. A., Sultana, R., Islam, F., et al. (2004). Prevalence of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh. International Journal of Antimicrobial Agents, 24(5), 508–510. https://doi.org/10.1016/j.ijantimicag.2004.05.007
Rudresh, S. M., & Nagarathnamma, T. (2011). Two simple modifications of modified three-dimensional extract test for detection of AmpC β-lactamases among the members of family Enterobacteriaceae. Chronicles of Young Scientists, 2(1), 42–46. https://doi.org/10.4103/2229-5186.79349
Sasirekha, B. (2013). Prevalence of ESBL, AmpC β-lactamases and MRSA among uropathogens and its antibiogram. EXCLI Journal, 12, 81–88.
Shahid, M., Malik, A., Agrawal, M., & Singhal, S. (2004). Phenotypic detection of extended-spectrum and AmpC β-lactamases by a new spot-inoculation method and modified three-dimensional extract test: Comparison with the conventional three-dimensional extract test. Journal of Antimicrobial Chemotherapy, 54(4), 684–687. https://doi.org/10.1093/jac/dkh389
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015). Risk factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals. Saudi Journal of Biological Sciences, 22(1), 37–41. https://doi.org/10.1016/j.sjbs.2014.05.006
Sharma, M., Pathak, S., & Srivastava, P. (2013). Prevalence and antibiogram of ESBL-producing Gram-negative bacilli and further molecular characterization of ESBL-producing Escherichia coli and Klebsiella spp. Journal of Clinical and Diagnostic Research, 7(10).
Singhal, S., Mathur, T., Khan, S., Upadhyay, D. J., Chugh, S., Gaind, R., et al. (2005). Evaluation of methods for AmpC β-lactamase in Gram-negative clinical isolates from tertiary care hospitals. Indian Journal of Medical Microbiology, 23(2), 120–124. https://doi.org/10.4103/0255-0857.16053
Sinha, P., Sharma, R., Rishi, S., Sharma, R., Sood, S., & Pathak, D. (2008). Prevalence of extended-spectrum β-lactamase and AmpC β-lactamase producers among Escherichia coli isolates in a tertiary care hospital in Jaipur. Indian Journal of Pathology and Microbiology, 51(3), 367–369. https://doi.org/10.4103/0377-4929.42512
Stürenburg, E., Lang, M., Horstkotte, M. A., Laufs, R., & Mack, D. (2004). Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum β-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria. Journal of Antimicrobial Chemotherapy, 54(5), 870–875. https://doi.org/10.1093/jac/dkh449
Talukdar, P. K., Rahman, M., Nabi, A., Islam, Z., Hoque, M. M., et al. (2013). Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from the household water supply in Dhaka, Bangladesh. PLoS ONE, 8(4), e61090. https://doi.org/10.1371/journal.pone.0061090
Taneja, N., Singh, G., Singh, M., et al. (2012). High occurrence of blaCMY-1 AmpC β-lactamase-producing Escherichia coli in cases of complicated urinary tract infection from a tertiary health care centre in North India. Indian Journal of Medical Research, 136, 289–291.
Tenover, F. C., Mohammed, M. J., Gorton, T. S., & Dembek, Z. (1999). Detection and reporting of organisms producing extended-spectrum β-lactamases: Survey of laboratories in Connecticut. Journal of Clinical Microbiology, 37(12), 4065–4070. https://doi.org/10.1128/JCM.37.12.4065-4070.1999
Wadekar, M. D., Anuradha, K., & Venkatesha, D. (2013). Phenotypic detection of ESBL and MBL in clinical isolates of Enterobacteriaceae. International Journal of Current Research and Academic Review, 1(3), 89–95.
Wayne, P. A. (2010). Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twentieth informational supplement M100-S20. CLSI.
Yu, Y., Zhou, W., Chen, Y., Ding, Y., & Ma, Y. (2002). Epidemiological and antibiotic-resistant study on extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province. Chinese Medical Journal, 115(10), 1479–1482.